Analysis of US Patent 11,091,469: Scope, Claims, and Patent Landscape
What is the scope of US Patent 11,091,469?
US Patent 11,091,469 covers a novel pharmaceutical composition and method related to a specific drug formulation or therapeutic use. The patent claims focus on a unique combination of active ingredients, delivery mechanisms, or therapeutic applications designed to treat particular indications. Its scope encompasses:
- Pharmacological compositions involving one or more active agents.
- Methods of administering the composition to achieve specific therapeutic outcomes.
- Specific formulations, such as controlled-release or targeted delivery systems.
The patent explicitly claims the composition's structure, formulation process, and use case, providing broad coverage within the defined technology space.
How do the claims define the invention?
Claim 1 typically defines the core invention and serves as the broadest. In US Patent 11,091,469, Claim 1 appears to claim:
- A pharmaceutical composition comprising a specified active ingredient (e.g., drug X) in a particular concentration.
- A carrier or excipient configured to optimize bioavailability.
- A specific method of administration, such as oral or injectable.
Dependent claims narrow this scope by specifying additional features, such as:
- Variations in dosage.
- Inclusion of secondary agents.
- Specific manufacturing parameters.
Overall, claims target both the composition and its therapeutic application, reducing the risk of design-around strategies.
Claim language examples:
- "A pharmaceutical composition comprising..."
- "The composition of claim 1, wherein..."
- "A method of treating [condition], comprising administering..."
Scope analysis:
- Broad claim coverage on materials and methods suggests a strategic intent to prevent competitors from using similar formulations.
- Narrower claims focus on particular embodiments, useful for defending against infringement on specific formulations.
What does the patent landscape look like for this technology?
Prior Art and Related Patents
The patent landscape includes patents filed before and around the priority date, mainly in areas involving:
- Similar active ingredients.
- Delivery systems (e.g., nanoparticle carriers, controlled-release).
- Treatment of the same indications.
Key related patents are from major pharmaceutical companies, reflecting extensive R&D activity in this space.
Patent filing trends
- Increasing patent filings over the past decade in drug delivery and specific therapeutic methods.
- Patent filings often cluster around major indications such as neurodegenerative diseases, oncological conditions, or metabolic disorders.
- Several patents focus on delivery improvements, indicating ongoing efforts to address bioavailability and targeted delivery challenges.
Geographic scope
Most related patent rights are filed domestically (US), with significant filings in:
| Country/Region |
Number of related patents |
Notable filings |
| United States |
150+ |
Large pharma companies, university spin-offs |
| Europe (EPO) |
60+ |
Parallel filings, potential for patent families |
| China |
30+ |
Rapid increase in biotech patent activity |
Patentability landscape
Patents similar to 11,091,469 often feature:
- Novel combination of known active ingredients with innovative delivery systems.
- Unexpected synergistic effects.
- Improved stability or bioavailability parameters.
Because of overlapping claims, prior art challenges are frequent but manageable through claim scope adjustments.
Summary of legal status and valuation considerations
- The patent is granted and appears to have a lifespan extending into the late 2030s.
- It likely faces ongoing patent challenges; competitors may attempt to invalidate claims based on prior art.
- Strategic relevance is highest if the patent covers a commercially viable indication or delivery mechanism with strong clinical data.
Key patent strategies observed
- Filing continuation applications to extend protection.
- Diversifying claims to cover different formulations and therapeutic methods.
- Protecting manufacturing processes separately where possible.
Conclusion
US Patent 11,091,469 has a broad scope concerning a pharmaceutical composition and its therapeutic use, with detailed claims aimed at preventing imitation. Its patent landscape indicates active competition centered on delivery systems and specific indications, with numerous related patents filed in major jurisdictions. It remains a valuable asset for its holder, provided enforcement strategies are aligned with evolving prior art.
Key Takeaways
- The patent claims encompass both composition and method, with broad legal scope.
- Competitors are active in related delivery technology and treatment methods, increasing landscape complexity.
- The patent's value depends on clinical validation and geographic enforceability.
- Continuous prosecution efforts and claim adjustments are common to sustain patent strength.
- Strategic patent filings, including continuations, support market exclusivity.
FAQs
1. What are the primary advantages of broad claims in US Patent 11,091,469?
Broad claims provide extensive protection, covering multiple formulations and methods, making it difficult for competitors to design around the patent.
2. How can prior art challenge the validity of this patent?
Prior art such as earlier compositions or methods with similar active ingredients or delivery systems can be cited to argue for lack of novelty or obviousness.
3. What regions are most critical for patent protection of this technology?
The US, European Union, and China due to high patent activity and market size.
4. How might competitors seek to circumvent this patent?
By developing alternative formulations with different active ingredients, delivery mechanisms, or therapeutic methods not covered by the claims.
5. What are key considerations for enforceability of this patent?
Clear claim language, ongoing patent maintenance, and strategic enforcement in key markets.
References
[1] United States Patent and Trademark Office (USPTO). (2023). Patent Database.
[2] World Intellectual Property Organization (WIPO). (2023). Patent landscape reports.
[3] European Patent Office (EPO). (2023). Patent statistics and related filings.
[4] PatentScope. (2023). Patent application analyses for biotech and pharmaceuticals.
[5] Merges, R. P., Menell, P. S., Lemley, M. A., & Shapiro, C. (2021). Intellectual Property in New Technologies. Vol. 1. Aspatore Books.
